(PharmaNewsWire.Com, October 05, 2017 ) The Asia Pacific Anatomy Pathology Market was worth USD 2.59 billion in 2016 and is estimated to be growing at a CAGR of 7.92%, to reach USD 3.79 billion by 2021. The market is displaying obvious potential in the said determining period. Anatomy Pathology is the branch of medicine that deals with diagnosis of diseases based on the various levels of examinations of organs and tissues.
Anatomy Pathology features the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues. The data generated by Anatomy Pathology is further analysed and is used by doctors for a better health management. Anatomy Pathology is basically one of the branch of the pathology stream, other being the Clinical Pathology.
With the enormous number of ongoing developments and innovations in the healthcare, rising spending capabilities and increasing awareness of the people in this region, there has also been a rise in the market. People have also become prone to more and more harmful diseases as the time has changed because of increasing adaptability of micro-organisms against various medications. This market is facing challenges mainly competing with the Physician Groups, like speciality physicians merging or adding ancillary services and large commercial labs. There is a constant significant reimbursement pressure. Awareness is increasing in this region about diseases at a very fast rate, still overall awareness of the people is very less. These factors may act as growth hurdles for the Anatomy Pathology Market in this region.
Asia Pacific Anatomy Pathology Market Segmentation
• Product o Instruments o Accessories
• End-User o Diagnostics Lab o Hospitals o Physicians' Office Lab
• Application o Lymphoma o Breast o Lung o Cervical o Colorectal o Prostate
The Asia Pacific Anatomy Pathology Market is geographically segmented into India, South Korea, China, Japan and Australia. Asia Pacific is one of the most lucrative markets for the growth of Anatomy Pathology market and is projected to grow the highest during the forecast period. Factors such as growing demographics and emerging economies in countries such as India and China are anticipated to lead the growth of the market in this region. The market in this region is highly monopolised in this region. Some of the major companies dominating the market in this region are Sakura Finetechnical Co., Ltd. (Japan), MetroPolis (India) and IBISWorld’s Pathology Services (Australia).
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
